Positron (OTCMKTS:POSC – Get Free Report) announced its quarterly earnings data on Friday. The company reported ($0.03) earnings per share (EPS) for the quarter, Zacks reports. Positron had a negative net margin of 2,279.55% and a negative return on equity of 2,415.88%.
Positron Price Performance
POSC stock traded down $0.05 during midday trading on Friday, hitting $1.64. The stock had a trading volume of 9,943 shares, compared to its average volume of 41,016. The firm has a market cap of $54.28 million, a PE ratio of -5.12 and a beta of 0.67. Positron has a 12-month low of $1.27 and a 12-month high of $2.74. The company’s 50-day moving average price is $1.74 and its 200 day moving average price is $1.82.
Positron Company Profile
Positron Corporation (OTCMKTS: POSC) is a medical technology company focused on positron emission tomography (PET), a nuclear-imaging technique used to support the diagnosis and management of disease. Its activities include the development, manufacture and distribution of PET imaging systems and related products for healthcare providers. The company has emphasized cardiac PET imaging, an application that can help physicians evaluate heart function and blood flow. Positron’s product offerings have included dedicated PET equipment, such as the Attrius PET system, along with related imaging and radiopharmaceutical solutions.
Read More
- Five stocks we like better than Positron
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Positron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Positron and related companies with MarketBeat.com's FREE daily email newsletter.
